FDA Changes Fluoroquinolone Label But Denies Citizen Petition on Mitochondrial Toxicity

On Thursday May 12, 2016 the FDA contacted those who have been pursuing label changes for the Fluoroquinolones and issued a public statement that the FDA is requiring label changes for antibacterial drugs called fluoroquinolones

Dr. Bennett Publishes Paper on Fluoroquinolone Neuropsychiatric & Mitochondrial Toxicity

Dr. Charles Bennett has been able to successfully publish a paper titled "Fluoroquinolone-Related Neuropsychiatric and Mitochondrial Toxicity: a collaborative investigation by scientists and members of a social network."